PRME

Prime Medicine, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website rimemedicine.com
Employees(FY) 175
ISIN US74168J1016

Performance

-30.79%

-31.74%

-34.0%

-57.77%

-66.25%

YTD

-56.98%

Profile

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. The company offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. It has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. Prime Medicine, Inc. was incorporated in 2019 and is based in Cambridge, Massachusetts.

Advanced Technical Analysis

Technical Analysis of PRME 2024-11-20

The stock indicators reflect a predominantly bearish sentiment, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 40 suggesting a neutral stance, and a Technical Score of 25 reinforcing the overall bearish outlook. This combination signals caution for potential investors, as the prevailing trend appea...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of PRME

Stock Rank

Recent News & Updates

2024-11-14 07:10
Is Prime Medicine (NASDAQ:PRME) In A Good Position To Deliver On Growth Plans?(Simply Wall St.)
2024-11-12 16:00
Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates(GlobeNewswire)
2024-11-12 03:00
Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates(Globenewswire)
2024-11-06 16:00
Prime Medicine to Participate in Upcoming Investor Conferences(GlobeNewswire)
2024-11-06 03:00
Prime Medicine to Participate in Upcoming Investor Conferences(Globenewswire)
2024-10-28 10:00
12 High-Growth Stocks That Could Deliver Parabolic Returns(Motley Fool)
2024-10-24 08:00
Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress(GlobeNewswire)
2024-10-23 20:00
Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson's Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress(Globenewswire)
2024-10-15 21:45
Why I Keep Buying These 14 Incredible Growth Stocks(Yahoo Finance)
2024-10-15 08:00
Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings(GlobeNewswire)
2024-10-14 20:00
Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson's Disease, at Upcoming Scientific Meetings(Globenewswire)
2024-10-01 14:44
PRME Stock Rises 11.8% on Collaboration With Bristol Myers(Zacks)
2024-09-30 21:33
BMS and Prime ink potential $3.5bn deal to develop T cell therapies(Yahoo Finance)
2024-09-30 09:10
Sector Update: Health Care Stocks Steady Premarket Monday(MT Newswires)
2024-09-30 08:49
Sector Update: Health Care(MT Newswires)
2024-09-30 06:08
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday(Yahoo Finance)
2024-09-29 20:38
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline(Yahoo Finance)
2024-09-29 19:01
Prime Medicine Unveils Strategically Focused Pipeline(Globenewswire)
2024-09-29 19:00
Prime Medicine Announces Strategic Research Collaboration and License Agreement with Bristol Myers Squibb to Develop and Commercialize Multiple Prime Edited Ex Vivo T-Cell Therapies(Globenewswire)
2024-09-29 18:30
Prime to narrow gene editing research as it strikes deal with Bristol Myers(Yahoo Finance)
2024-08-28 08:15
2 Growth Stocks That Could Make You Richer(Motley Fool)
2024-08-28 08:00
Prime Medicine to Participate in Upcoming Investor Conferences(GlobeNewswire)
2024-08-27 20:00
Prime Medicine to Participate in Upcoming Investor Conferences(Globenewswire)
2024-08-08 08:00
Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates(GlobeNewswire)
2024-08-07 20:00
Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates(Globenewswire)
2024-07-31 13:53
Prime Medicine (PRME) Stock: Buy or Sell Before Q2 Earnings?(Zacks)
2024-07-19 10:00
Prime Medicine (PRME) Gains 16.4% in 3 Months: Buy Now or Wait?(Zacks)
2024-07-08 17:44
Prime Medicine, Inc. (PRME): Why Do Analysts Love This Shorted Stock Right Now?(Insider Monkey)
2024-07-08 05:44
Prime Medicine, Inc. (PRME): Why Do Analysts Love This Shorted Stock Right Now?(Insidermonkey)
2024-07-08 00:30
10 Most Shorted Stocks That Are Loved by Analysts(Insidermonkey)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.